Similar articles

• An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase.

  Chamorro C, Camarasa MJ, Pérez-Pérez MJ, de Clercq E, Balzarini J, San Félix A. Chamorro C, et al. Antivir Chem Chemother. 1998 Sep;9(5):413-22. Antivir Chem Chemother. 1998. PMID: 9875394
• Design and synthesis of α-carboxy nucleoside phosphonate analogues and evaluation as HIV-1 reverse transcriptase-targeting agents.

  Keane SJ, Ford A, Mullins ND, Maguire NM, Legigan T, Balzarini J, Maguire AR. Keane SJ, et al. J Org Chem. 2015 Mar 6;80(5):2479-93. doi: 10.1021/jo502549y. Epub 2015 Jan 9. J Org Chem. 2015. PMID: 25532055
• Anti-HIV activity of new substituted 1,3,4-oxadiazole derivatives and their acyclic nucleoside analogues.

  El-Sayed WA, El-Essawy FA, Ali OM, Nasr BS, Abdalla MM, Abdel-Rahman AA. El-Sayed WA, et al. Z Naturforsch C J Biosci. 2009 Nov-Dec;64(11-12):773-8. doi: 10.1515/znc-2009-11-1203. Z Naturforsch C J Biosci. 2009. PMID: 20158144
• Correlation of molecular conformation and activity of reverse transcriptase inhibitors.

  Van Roey P, Taylor EW, Chu CK, Schinazi RF. Van Roey P, et al. Ann N Y Acad Sci. 1990;616:29-40. doi: 10.1111/j.1749-6632.1990.tb17825.x. Ann N Y Acad Sci. 1990. PMID: 1706572 Review. No abstract available.
• Nucleoside reverse transcriptase inhibitors and HIV mutagenesis.

  Jewell NA, Chen R, Raices R, Mansky LM. Jewell NA, et al. J Antimicrob Chemother. 2003 Oct;52(4):547-50. doi: 10.1093/jac/dkg387. Epub 2003 Sep 1. J Antimicrob Chemother. 2003. PMID: 12951341 Review. No abstract available.